Technical Analysis for ATNM - Actinium Pharmaceuticals, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Historical ATNM trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Slingshot Bearish | Bearish Swing Setup | 0.00% | |
| Bullish Engulfing | Bullish | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Hammer Candlestick | Bullish | 1.68% | |
| Lizard Bullish | Bullish Day Trade Setup | 1.68% | |
| Wide Bands | Range Expansion | 1.68% | |
| Down 3 Days in a Row | Weakness | 1.68% | |
| Lower Bollinger Band Touch | Weakness | 1.68% | |
| Wide Bands | Range Expansion | -0.63% | |
| 180 Bearish Setup | Bearish Swing Setup | -1.62% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time | |
|---|---|---|
| 10 DMA Resistance | about 12 hours ago | |
| Trending on StockTwits | about 12 hours ago | |
| Up 5% | about 12 hours ago | |
| Rose Above 10 DMA | about 13 hours ago | |
| Lizard Bullish Entry | about 13 hours ago |
Get a Trading Sidekick!
- Earnings date: 06/29/2020
Actinium Pharmaceuticals, Inc. Description
Actinium Pharmaceuticals, Inc., formerly Cactus Ventures, Inc. is a biopharmaceutical company developing cancer drugs. The Company's advanced products are Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), in human clinical trials for acute myeloid leukemia (AML) and Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used in myeloconditioning for hematopoietic stem cells transplantation (HSCT) in various indications. In addition, the Ac-225 based drugs development relies on the patented Alpha Particle Immunotherapy Technology (APIT) platform technology co-developed with Memorial Sloan- Kettering Cancer Center (MSKCC), a related institution. The APIT technology couples monoclonal antibodies (mAb) with extremely potent but comparatively safe alpha particle emitting radioactive isotopes, in particular actinium 225 and bismuth 213.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cancer Immunology Natural Sciences Immunotherapy Antibodies Monoclonal Antibodies Monoclonal Antibody Chemical Elements Stem Cells Acute Myeloid Leukemia Platform Technology Transplantation Cancer Center Hematopoietic Stem Cell Actinides Bismuth Iodine Cactus Immunotherapy Technology Kettering Cancer Center Memorial Sloan
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 19.47 |
| 52 Week Low | 4.8 |
| Average Volume | 550,573 |
| 200-Day Moving Average | 10.27 |
| 50-Day Moving Average | 8.62 |
| 20-Day Moving Average | 8.59 |
| 10-Day Moving Average | 8.00 |
| Average True Range | 0.52 |
| ADX | 31.24 |
| +DI | 14.07 |
| -DI | 31.08 |
| Chandelier Exit (Long, 3 ATRs ) | 8.60 |
| Chandelier Exit (Short, 3 ATRs ) | 8.60 |
| Upper Bollinger Band | 9.92 |
| Lower Bollinger Band | 7.26 |
| Percent B (%b) | 0.23 |
| BandWidth | 30.92 |
| MACD Line | -0.30 |
| MACD Signal Line | -0.23 |
| MACD Histogram | -0.0652 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 8.84 | ||||
| Resistance 3 (R3) | 8.85 | 8.55 | 8.68 | ||
| Resistance 2 (R2) | 8.55 | 8.30 | 8.54 | 8.63 | |
| Resistance 1 (R1) | 8.21 | 8.15 | 8.38 | 8.20 | 8.57 |
| Pivot Point | 7.91 | 7.91 | 7.99 | 7.90 | 7.91 |
| Support 1 (S1) | 7.57 | 7.66 | 7.74 | 7.56 | 7.19 |
| Support 2 (S2) | 7.27 | 7.51 | 7.26 | 7.13 | |
| Support 3 (S3) | 6.94 | 7.27 | 7.08 | ||
| Support 4 (S4) | 6.92 |
